The healthcare community is buzzing by retatrutide, a new dual GIP and GLP-1 target that’s showing significant results in early research. This treatment works by imitating natural hormones to affect appetite and promote feelings of get more info fullness , ultimately contributing to substantial weight decrease. While presently under evaluation an